Treating cancer with radioactive scorpion venom

Radioactive venom from an Israeli scorpion species might not be the first thing one would think of to treat a form of brain cancer called glioma. A company called TransMolecular that's pushing the idea, though, announced "favorable safety results" from a second-phase trial of such a substance (click for PDF).

The substance, called 131I-TM-601, is actually a synthetic version of a chemical in the scorpion venom. It's coupled with a radioactive isotope of iodine with an atomic weight of 131. The 131I-TM-601 binds with receptors in the cancer cells but leaves healthy cells alone, TransMolecular said. Then the radioactive decay of the iodine in close proximity to the tumor cells kills them.

The approach is similar to a treatment for thyroid cancer; the thyroid gland has an affinity for iodine, so injections of radioactive iodine-131 are concentrated at the cancer site. The Food and Drug Administration approved investigations of 131I-TM-601 in 2002.

Featured Video
This content is rated TV-MA, and is for viewers 18 years or older. Are you of age?
Sorry, you are not old enough to view this content.

Microsoft leaves Apple in the dust with tablet and laptop innovation in 2015

Will there be one Apple Ring to rule them all? That's what a patent application says. Plus, building the thinnest gadget isn't innovation anymore and Apple just got a reality check from Microsoft.

by Brian Tong